Clinical Trial Update: Melatonin for Nocturia in Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating melatonin for nocturia in Parkinson's disease. The sponsor is University College London, and the current status is unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia
• Parkinson Disease

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: University College, London | Conditions: Parkinson's Disease, Nocturia | Phase 2 | Status: UNKNOWN